This brings up the question of “what is intellectual property” and how are patents filed and protected in this area and it goes beyond the 
pharmaceutical side of the business, which is what most of us might think about. Who knows where the case will lead and how long, but hopefully it won’t have an impact to slow down personalized medicine growth and technology. BD
NEW YORK (GenomeWeb News) – Illumina has filed a lawsuit against Affymetrix alleging infringement its array technology.
The suit, filed yesterday in the US District Court for the Western District of Wisconsin, alleges that a variety of Affymetrix products infringe Illumina's US Patent No. 7,510,841, entitled, "Methods of Making and Using Composite Arrays for the Detection of a Plurality of Target Analytes." The patent was issued on March 31, 2009.
The Affy products named in the suit include the GeneChip HT RG-230 PM Array Plate, the GeneChip HT Array Plate Scanner, the GeneChip HT 3' IVT Express Kit, the GeneChip Array Station, and the GeneTitan Institute.
The Affy products named in the suit include the GeneChip HT RG-230 PM Array Plate, the GeneChip HT Array Plate Scanner, the GeneChip HT 3' IVT Express Kit, the GeneChip Array Station, and the GeneTitan Institute.
Related Reading:
0 comments :
Post a Comment